Dr. Reddy's Laboratories has entered the inhaler segment in India with the launch of CombihaleTM - a combination of a steroid and a long acting bronchodilator. It is used in the treatment of asthma and is available in two combinations, CombihaleTM FF and CombihaleTM FB.
CombihaleTM would be available along with 'Redihaler', a dry powder inhalation device that was designed in-house and which will initially be given free of cost with CombihaleTM.
The company made this announcement during the trading hours today, 25 September 2008.
BSE tips
No comments:
Post a Comment